<code id='9ABFE02D13'></code><style id='9ABFE02D13'></style>
    • <acronym id='9ABFE02D13'></acronym>
      <center id='9ABFE02D13'><center id='9ABFE02D13'><tfoot id='9ABFE02D13'></tfoot></center><abbr id='9ABFE02D13'><dir id='9ABFE02D13'><tfoot id='9ABFE02D13'></tfoot><noframes id='9ABFE02D13'>

    • <optgroup id='9ABFE02D13'><strike id='9ABFE02D13'><sup id='9ABFE02D13'></sup></strike><code id='9ABFE02D13'></code></optgroup>
        1. <b id='9ABFE02D13'><label id='9ABFE02D13'><select id='9ABFE02D13'><dt id='9ABFE02D13'><span id='9ABFE02D13'></span></dt></select></label></b><u id='9ABFE02D13'></u>
          <i id='9ABFE02D13'><strike id='9ABFE02D13'><tt id='9ABFE02D13'><pre id='9ABFE02D13'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          entertainment

          author:fashion    - browse:45
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore